Blood Neoplasia is a peer-reviewed english-language open-access journal published by Elsevier in United States, operating under an open-access model since 2024. The journal covers Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs.
Authors are required to pay an article processing charge to publish in Blood Neoplasia; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY-NC-ND license (see other journals using this license).
To date, Blood Neoplasia has published 243 articles. Articles are minted with DOIs through the prefix 10.1016. All submissions undergo plagiarism screening before peer review.
Keywords
hematology, hematologic malignancy, leukemia, lymphoma, multiple myeloma, myeloproliferative neoplasms
At a glance
- Publisher
- Elsevier
- Country
- United States
- Primary language
- English
- License
- CC BY-NC-ND
- Peer review
- Anonymous peer review
- OA since
- 2024
- Review time
- 14 weeks
- DOI prefix
10.1016- Plagiarism check
- Yes
ISSN
- electronic
- 2950-3280
Frequently asked questions
Is Blood Neoplasia peer-reviewed?
Does Blood Neoplasia charge an article processing charge (APC)?
What subjects does Blood Neoplasia publish?
What languages does Blood Neoplasia accept?
What is the ISSN of Blood Neoplasia?
2950-3280 (electronic).